MaxCyte, Inc. Share Price
MXCTMaxCyte, Inc. Stock Performance
Open $1.03 | Prev. Close $1.06 | Circuit Range N/A |
Day Range $1.01 - $1.07 | Year Range $0.65 - $2.40 | Volume 33,645 |
Average Traded $1.04 |
MaxCyte, Inc. Share Price Chart
About MaxCyte, Inc.
MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. It also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.
MaxCyte, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
19-May-26 | $1.03 | $1.05 | +0.00% |
19-May-26 | $1.03 | $1.05 | -0.94% |
18-May-26 | $1.01 | $1.06 | +0.95% |
15-May-26 | $1.07 | $1.05 | -4.11% |
14-May-26 | $1.01 | $1.09 | +7.99% |
13-May-26 | $0.93 | $1.01 | +23.21% |
12-May-26 | $0.79 | $0.82 | +1.11% |